Nearly a quarter of patients with COVID-19 experience hair loss within six months of infection, with women at higher risk, according to a new study.
Researchers looked at several long-term symptoms Wuhan, China, where the virus first appeared at the end of 2019, and revealed that 359 of 1,655 hospital patients suffered from it.
COVID news live from UK and around the world
The study, published in the medical journal The Lancet, also found that fatigue, shortness of breath, dizziness and joint pain were the “main long-term symptoms” of coronavirus.
The authors of the article said that the long-term health consequences COVID-19[female[feminine remain “largely unclear”.
The study involved patients who were discharged from Jin Yin-tan Hospital between January 7 and May 29, 2020 after being treated for COVID.
The researchers followed them up six months later, when the patients were interviewed with questionnaires to assess symptoms, physically examined with a six-minute walk test, and blood tests.
The results revealed that 63% of the patients suffered from fatigue or muscle weakness, 26% suffered from problems sleeping, 23% from anxiety or depression, and 22% from hair loss.
It also found that 76% of patients reported at least one symptom six months after the onset of the first symptom, with the proportion higher in women.
Patients who were seriously ill with the virus were more likely to suffer from muscle weakness and depression.
The authors said: “We found that six months after the onset of symptoms, most patients approved of at least one symptom, particularly fatigue or muscle weakness, sleep disturbances, and anxiety or depression.
“More seriously ill patients had an increased risk of abnormal pulmonary diffusion, fatigue or muscle weakness, and anxiety or depression.”
In a three-month follow-up survey of 538 patients with COVID-19, researchers found that “physical decline or fatigue, post-activity polypnea (rapid breathing or panting) and alopecia were more common in women than men ”.
The study also looked at manifestations and long-term extrapulmonary organ death during follow-up, with some patients recently diagnosed with diabetes and venous thromboembolic disease – that is, when a blood clot develops. form.
The authors added that being female and the severity of illness from the virus were also risk factors for “persistent psychological problems,” such as stress and anxiety.
The NHS lists fatigue, shortness of breath and dizziness among some of its long-term symptoms of COVID-19, but hair loss is not included in its list.